Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Aer Therapeutics, a clinical-stage biopharmaceutical company developing therapeutic solutions for muco-obstructive lung diseases.
Tune Therapeutics is an epigenetic programming platform for the treatment of disease.
Ten63 Therapeutics is a venture-backed startup developing durable therapeutics against some of the world's most lethal diseases.
Endogenex develops an endoscopic procedure to help patients with type 2 diabetes regain control of their blood glucose levels.
AtaCor Medical is a medical device maker.
Contego Medical develops a family of novel embolic protection devices.
Cardiosense is a digital biomarker platform that provides multi-sensor devices and proprietary algorithms to detect early signs of diseases.
Wildflower is a women’s health solutions company, specializing in digital and value-based care.
Synaptrix is a healthcare company that offers medical products for postoperative pain treatment.
Artizan Biosciences focuses on drug discovery and development for diseases involving the human intestinal microbiota.
Axonis Therapeutics is a neuro-focused biotechnology company that focuses on the development of novel neuromedicines.
Elligo Health Research brings clinical research to physician practices and accelerate the development of medical device and therapies.
Pharaoh Neuro develops a neurapheresis cerebrospinal fluid management system for neurological patients.
Boomerang Medical is a bioelectronic medical enterprise.
Altis Biosystems is a biotechnology company developing research tools for the pharma and biotech industries.
BEKhealth harnesses its AI-powered chart abstraction and patient-matching platform to optimize clinical research enrollment.
This company is a Boston-based biopharmaceutical company developing immune-based approaches.
iVEAcare develops innovative neuromodulation therapy to treat unmet clinical needs.
Clearside BioMedical is an ophthalmic company that specializes in the research, development, and commercialization of therapeutic products.
CREATE Medicines is a clinical stage mRNA-immunotherapy company developing novel therapies for cancer and autoimmune diseases.
RapidPulse is a privately held medical device company that develops minimally invasive vascular products for ischemic stroke
Code Biotherapeutics is a next-generation gene therapy company pioneering the development of targeted non-viral gene therapies.
WalletFi is the Subscription Management solution for Financial Institutions and Fintechs
Neuro Tronik develops a medical device as an alternative for the drugs used currently to treat heart failures.
Hatteras Venture Partners has invested in 63 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Hatteras Venture Partners's top investment sectors include Health Care, Biotechnology, Medical, Medical Device, Therapeutics. The firm invests across 26 different industry categories.
Among tracked funding rounds, Tune Therapeutics received $175.0M in a Series B round. Hatteras Venture Partners's total known invested capital is $2.0B.
Hatteras Venture Partners's average investment size is $35.7M across its portfolio of 63 companies.
Recent Hatteras Venture Partners portfolio additions include Aer Therapeutics, Tune Therapeutics, Ten63 Therapeutics, Endogenex, AtaCor Medical. These companies were founded in 2020 or later.